In our study, high C-RP levels differ statistically between the ambulatory, hospitalized, and dead patients (Figure 4C), which suggested that CRP is a marker of disease aggravation in COVID-19 patients; these results stand accordingly with other published studies [34]. This evidence concerns the gene CRP and COVID-19.